[go: up one dir, main page]

DK320287D0 - Fremgangsmaade til anvendelse af barl til udskillelse af fremmede proteiner - Google Patents

Fremgangsmaade til anvendelse af barl til udskillelse af fremmede proteiner

Info

Publication number
DK320287D0
DK320287D0 DK320287A DK320287A DK320287D0 DK 320287 D0 DK320287 D0 DK 320287D0 DK 320287 A DK320287 A DK 320287A DK 320287 A DK320287 A DK 320287A DK 320287 D0 DK320287 D0 DK 320287D0
Authority
DK
Denmark
Prior art keywords
barl
alien
proteins
separation
procedure
Prior art date
Application number
DK320287A
Other languages
English (en)
Other versions
DK320287A (da
Inventor
Vivian L Mackay
Original Assignee
Vivian L Mackay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vivian L Mackay filed Critical Vivian L Mackay
Publication of DK320287A publication Critical patent/DK320287A/da
Publication of DK320287D0 publication Critical patent/DK320287D0/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/58Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
    • C12N9/60Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi from yeast
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/10Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/50Fusion polypeptide containing protease site
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK320287A 1985-10-25 1987-06-23 Fremgangsmaade til anvendelse af barl til udskillelse af fremmede proteiner DK320287D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79130585A 1985-10-25 1985-10-25
PCT/US1986/002198 WO1987002670A1 (en) 1985-10-25 1986-10-20 Method of using bar1 for secreting foreign proteins

Publications (2)

Publication Number Publication Date
DK320287A DK320287A (da) 1987-06-23
DK320287D0 true DK320287D0 (da) 1987-06-23

Family

ID=25153298

Family Applications (1)

Application Number Title Priority Date Filing Date
DK320287A DK320287D0 (da) 1985-10-25 1987-06-23 Fremgangsmaade til anvendelse af barl til udskillelse af fremmede proteiner

Country Status (13)

Country Link
EP (1) EP0243465A1 (da)
JP (1) JP2523562B2 (da)
CN (1) CN1027179C (da)
AU (2) AU6543286A (da)
CA (1) CA1316133C (da)
CZ (1) CZ284251B6 (da)
DK (1) DK320287D0 (da)
FI (1) FI872801A0 (da)
HU (1) HU206897B (da)
IE (1) IE63822B1 (da)
SK (1) SK776486A3 (da)
UA (1) UA41863C2 (da)
WO (1) WO1987002670A1 (da)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK58285D0 (da) * 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
JP2730923B2 (ja) * 1987-10-02 1998-03-25 ザイモジェネティクス,インコーポレイティド Bar1分泌シグナル
US5206699A (en) * 1988-05-06 1993-04-27 Gersan Establishment Sensing a narrow frequency band of radiation and gemstones
WO1990001063A1 (en) * 1988-07-23 1990-02-08 Delta Biotechnology Limited New secretory leader sequences
JPH05505308A (ja) * 1990-03-13 1993-08-12 ハワイ・バイオテクノロジー・グループ・インコーポレイテツド アオパンカビ発現システム
DK82893D0 (da) * 1993-07-08 1993-07-08 Novo Nordisk As Peptid
EP2431462A3 (en) 1995-03-17 2012-05-23 Novozymes A/S Novel endoglucanases
BR9707807A (pt) 1996-03-01 1999-07-27 Novo Nordisk As Uso de uma composição farmacêutica composição farmacêutica processo de tratar doenças ou distúrbios associados com a regulação do apetite prejudicado e uso de um peptideo
DE60139110D1 (de) 2000-01-10 2009-08-13 Maxygen Holdings Ltd G-csf konjugate
DK1257295T3 (da) 2000-02-11 2009-08-10 Bayer Healthcare Llc Faktor VII eller VIIA-lignende molekyler
EP2080771A3 (en) 2001-02-27 2010-01-06 Maxygen Aps New interferon beta-like molecules
CN100567487C (zh) 2001-03-22 2009-12-09 诺沃挪第克健康护理股份公司 凝血因子vii衍生物
US6534059B2 (en) 2001-06-05 2003-03-18 Advanced Biotherapy, Inc. Compositions and methods for treating hyperimmune response in the eye
IL160897A0 (en) 2001-09-27 2004-08-31 Novo Nordisk Healthcare Ag Human coagulation factor vii polypeptides
CN101870729A (zh) 2003-09-09 2010-10-27 诺和诺德医疗保健公司 凝固因子ⅶ多肽
KR20080013878A (ko) 2005-04-18 2008-02-13 노보 노르디스크 에이/에스 Il-21 변이체
JP5366546B2 (ja) 2005-08-16 2013-12-11 ノボ・ノルデイスク・エー/エス 成熟インスリンポリペプチドの作製方法
WO2007031559A2 (en) 2005-09-14 2007-03-22 Novo Nordisk Health Care Ag Human coagulation factor vii polypeptides
US20100159512A1 (en) 2006-03-06 2010-06-24 Kurt Osther Method for the preparation of recombinant human thrombin and fibrinogen
WO2008030558A2 (en) 2006-09-08 2008-03-13 Ambrx, Inc. Modified human plasma polypeptide or fc scaffolds and their uses
EP2069502B1 (en) 2006-09-27 2014-02-26 Novo Nordisk A/S Method for making maturated insulin polypeptides
NZ580686A (en) 2007-05-02 2012-11-30 Ambrx Inc Modified interferon beta polypeptides and their uses
NZ603812A (en) 2007-11-20 2014-06-27 Ambrx Inc Modified insulin polypeptides and their uses
CN106928339A (zh) 2008-07-23 2017-07-07 Ambrx 公司 经修饰的牛g‑csf多肽和其用途
US8349325B2 (en) 2008-12-23 2013-01-08 Abbott Laboratories Soluble FMS-like tyrosine kinase-1 (sFLT-1) antibody and related composition, kit, methods of using, and materials and method for making
WO2010103038A1 (en) 2009-03-11 2010-09-16 Novo Nordisk A/S Interleukin-21 variants having antagonistic binding to the il-21 receptor
BR112012001070B1 (pt) 2009-07-17 2022-05-03 Omeros Corporation Composição de polipeptídeo associado à ficolina e uso da mesma
US9096843B2 (en) 2009-12-01 2015-08-04 Novo Nordisk A/S Peptidyl α-hydroxyglycine α-amidating lyases
MX2012006980A (es) 2009-12-21 2012-07-17 Ambrx Inc Polipeptidos de somatotropina porcina modificados y sus usos.
EP2805964A1 (en) 2009-12-21 2014-11-26 Ambrx, Inc. Modified bovine somatotropin polypeptides and their uses
AU2011222883B2 (en) 2010-03-05 2016-05-26 Omeros Corporation Chimeric inhibitor molecules of complement activation
US20110229921A1 (en) 2010-03-18 2011-09-22 Abbott Laboratories METHODS OF ASSAYING URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (uNGAL) IN THE PROGNOSIS OF CADAVERIC KIDNEY TRANSPLANT FUNCTION IN A PATIENT, INCLUDING A PATIENT DIAGNOSED WITH DELAYED GRAFT FUNCTION (DGF), A METHOD OF ASSAYING uNGAL IN THE ASSESSMENT OF RISK OF DGF IN A PATIENT DIAGNOSED WITH EARLY GRAFT FUNCTION (EGF), AND RELATED KITS
WO2011163558A1 (en) 2010-06-25 2011-12-29 Abbott Laboratories Materials and methods for assay of anti-hepatitis c virus (hcv) antibodies
PT2605789T (pt) 2010-08-17 2019-09-03 Ambrx Inc Polipeptidos de relaxina modificados e suas utilizações
AR083006A1 (es) 2010-09-23 2013-01-23 Lilly Co Eli Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas
US20120115244A1 (en) 2010-11-09 2012-05-10 Abbott Laboratories Materials and methods for immunoassay of pterins
ES2627117T3 (es) 2010-12-09 2017-07-26 Institut Pasteur Método basado en MGMT para obtener un rendimiento elevado de expresión de proteínas recombinantes
CN104114697A (zh) 2011-12-09 2014-10-22 巴斯德研究所 多重免疫筛选分析
US8993248B2 (en) 2011-12-31 2015-03-31 Abbott Laboratories Truncated human vitamin D binding protein and mutation and fusion thereof and related materials and methods of use
CA2861051C (en) 2012-02-09 2021-06-22 Var2 Pharmaceuticals Aps Targeting of chondroitin sulfate glycans
JP2015532307A (ja) 2012-10-15 2015-11-09 ノヴォ・ノルディスク・ヘルス・ケア・アーゲー 凝固因子viiポリペプチド
JP2014128262A (ja) * 2012-11-27 2014-07-10 Kirin Brewery Co Ltd 接合能を持つ酵母細胞株のスクリーニング方法
EP3788149A1 (en) 2018-05-01 2021-03-10 Ambrx, Inc. A method for optimizing antibody expression
CN112789504A (zh) 2018-07-13 2021-05-11 瓦克特诊断有限责任公司 使用重组疟疾蛋白var2csa分离胎儿来源的循环细胞
CN116948006A (zh) 2018-09-11 2023-10-27 北京泰德制药股份有限公司 白介素-2多肽偶联物及其用途
US20220009986A1 (en) 2018-10-19 2022-01-13 Ambrx, Inc. Interleukin-10 polypeptide conjugates, dimers thereof, and their uses
US20220226488A1 (en) 2019-02-12 2022-07-21 Ambrx, Inc. Compositions containing, methods and uses of antibody-tlr agonist conjugates
CA3174114A1 (en) 2020-03-11 2021-09-16 Ambrx, Inc. Interleukin-2 polypeptide conjugates and methods of use thereof
CA3175523A1 (en) 2020-04-13 2021-10-21 Antti Virtanen Methods, complexes and kits for detecting or determining an amount of a .beta.-coronavirus antibody in a sample
WO2022031804A1 (en) 2020-08-04 2022-02-10 Abbott Laboratories Improved methods and kits for detecting sars-cov-2 protein in a sample
TW202227449A (zh) 2020-08-20 2022-07-16 美商Ambrx 公司 抗體-tlr促效劑偶聯物、其方法及用途
WO2022147147A1 (en) 2020-12-30 2022-07-07 Abbott Laboratories Methods for determining sars-cov-2 antigen and anti-sars-cov-2 antibody in a sample
CA3213805A1 (en) 2021-04-03 2022-10-06 Feng Tian Anti-her2 antibody-drug conjugates and uses thereof
CN115806889B (zh) * 2022-09-28 2024-06-11 山东大学 一种提高基因表达水平的酿酒酵母工程菌及其构建方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4546082A (en) * 1982-06-17 1985-10-08 Regents Of The Univ. Of California E. coli/Saccharomyces cerevisiae plasmid cloning vector containing the alpha-factor gene for secretion and processing of hybrid proteins
US4613572A (en) * 1983-08-15 1986-09-23 Kansas State University Research Foundation Yeast BAR1 gene plasmid
JPS61247384A (ja) * 1984-10-18 1986-11-04 チモ−ジエネテイツクス インコ−ポレ−テツド 酵母中でプラスミノ−ゲン活性化因子を発現する方法
DE3537176C2 (de) * 1984-10-18 1994-06-09 Zymogenetics Inc Gewebeplasminogenaktivator und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
CA1316133C (en) 1993-04-13
AU676132B2 (en) 1997-03-06
EP0243465A1 (en) 1987-11-04
WO1987002670A1 (en) 1987-05-07
JPS63501614A (ja) 1988-06-23
SK279041B6 (sk) 1998-06-03
HUT43624A (en) 1987-11-30
DK320287A (da) 1987-06-23
CZ776486A3 (en) 1996-09-11
FI872801A (fi) 1987-06-24
JP2523562B2 (ja) 1996-08-14
IE862804L (en) 1987-04-25
UA41863C2 (uk) 2001-10-15
HU206897B (en) 1993-01-28
CN86107554A (zh) 1987-08-26
IE63822B1 (en) 1995-06-14
FI872801A0 (fi) 1987-06-24
AU7400391A (en) 1991-07-18
SK776486A3 (en) 1998-06-03
CN1027179C (zh) 1994-12-28
AU6543286A (en) 1987-05-19
CZ284251B6 (cs) 1998-10-14

Similar Documents

Publication Publication Date Title
DK320287A (da) Fremgangsmaade til anvendelse af barl til udskillelse af fremmede proteiner
DK174484D0 (da) Fremgangsmaade til chromatografisk fraktionering af plasmaproteiner
DK101588D0 (da) Fremgangsmaade til oligomerisering af olefinner
DK515789D0 (da) Fremgangsmaade til adskillelse af folinsyre
DK129085D0 (da) Fremgangsmaade til fremstilling af proteiner
DK431485A (da) Gensidig adskillelse af proteiner
DK260186A (da) Fremgangsmaade til fjernelse af det n-terminale metionin fra metionylproteiner
DK165250C (da) Fremgangsmaade til fremstilling af 2-amino-6-chlorpurin
DK47684D0 (da) Fremgangsmaade til fremstilling af proteinhydrolysater
DK296485D0 (da) Fremgangsmaade til fremstilling af l-phenylalanin
DK268186A (da) Fremgangsmaade til fremstilling af isatinforbindelser
DK78784D0 (da) Fremgangsmade til separering af oploesninger
DK453586D0 (da) Fremgangsmaade til fremstilling af 4-hydroxy-2-oxo-pyrrolidin-1-yl-acetamid
DK71683D0 (da) Fremgangsmade til fremstilling af protein til hydrolyse
DK258886D0 (da) Fremgangsmaade til fremstilling af alkyloxiraner
DK210586D0 (da) Fremgangsmaade til sammensvejsning af roerformede plastgenstande
DK509986A (da) Fremgangsmaade til fremstilling af aryl-cyanamider
DK354585D0 (da) Fremgangsmaade til fremstilling af terpinen-4-oler
DK163830C (da) Fremgangsmaade til fremstilling af riboflavin
DK390887A (da) Fremgangsmaade til fremstilling af 7alfa-acetylthiosteroider
DK61091D0 (da) Fremgangsmaade til fremstilling af 4-phenylpiperidinderivater
DK98792D0 (da) Fremgangsmaade til fremstilling af oxetanoner
DK546384A (da) Fremgangsmaade til genkendelse af tegn
DK28386D0 (da) Fremstilling af peptider
DK393883A (da) Fremgangsmaade til fraktionering af toerv

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment